Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07729540) titled 'Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea' on July 22.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Medical University of Silesia
Condition:
Rosacea
Intervention:
Device: Intense Pulsed Light (IPL) - Lumecca
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 29, 2025
Target Sample Size: 60
Countries of Recruitment:
Poland
To know more, visit https://clinicaltrials.gov/study/NCT0772...